Program Description
Despite recommendations for use of preexposure prophylaxis (PrEP), uptake among individuals at risk for HIV transmission remains low. The discrepancies in PrEP coverage and adherence also vary across patient groups with respect to gender, age, and race/ethnicity. Patients face several barriers with current antiretroviral combinations, such as pill burden with daily oral administration, but emerging long-acting injectable formulations may have the potential to reduce these challenges for patients. It is imperative that pharmacists and clinicians recognize these disparities in care to ensure access and promote adherence to PrEP therapy. Managed care providers have important roles in identifying persons most vulnerable to HIV transmission and collaborating with primary care clinicians and community pharmacists to increase initiation of PrEP in these patients. This activity will examine the impact of managed care interventions in improving cost-effectiveness and uptake of PrEP therapy in patient populations most at risk for HIV transmission as well as maximize efficacy of current and emerging agents.
Target audience: Health-system pharmacists, specialty pharmacists, managed care pharmacists, and pharmacy technicians
Type of activity: Application for pharmacists, knowledge for pharmacy technicians
Release date: June 28, 2022
Expiration date: August 28, 2022
Time to complete activity: 1.0 hour
Fee: Free
Pharmacist Educational Objectives
At the completion of this activity, participants will be able to:
- Investigate the current landscape of HIV preexposure prophylaxis (PrEP) as it relates to uptake and persistence of preventive therapy.
- Explore the disparities in HIV PrEP related to race, gender, age, and other social determinants of health.
- Distinguish between current and emerging treatment options for HIV PrEP, including their efficacy and safety profiles.
- Examine pharmacist interventions for improving accessibility to personalized HIV preventive care.
Pharmacy Technician Educational Objectives
At the completion of this activity, participants will be able to:
- Outline the current landscape of HIV preexposure prophylaxis (PrEP) as it relates to uptake and persistence of preventive therapy.
- Define the disparities in HIV PrEP related to race, gender, age, and other social determinants of health.
- Recognize patients who are appropriate for initiating PrEP therapy or who are nonadherent and refer them to a pharmacist for counseling.
Trisha A. Miller, PharmD, BCACP
Clinical Pharmacist, Ambulatory Care
Department of Pharmacy
University of Pittsburgh Medical Center Presbyterian Shadyside (Shadyside Campus)
Pittsburgh, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-22-275-L02-P and 0290-0000-22-276-L02-T. The activity is available for CE credit through August 28, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Trisha A. Miller, PharmD, BCACP, has no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms